Validation of myelin imaging technique in patients with MS
A study recently published in Annals of Neurology determined that SyMRI provides robust myelin quantification in patients with MS.The study published by Ouellette et al. concluded that SyMRI “provides robust myelin quantification that detects diffuse demyelination in normal-appearing tissue in multiple sclerosis, which is associated with both cognitive and clinical disability. Since the technique is fast with automatic post‐processing and FDA/CE clinical approval, it can be a clinically feasible biomarker that may be suitable to monitor myelin dynamics and evaluate treatments aiming at